摘要
目的探讨血脂康和辛伐他汀对于不稳定性心绞痛调脂作用的影响。方法选取106例不稳定性心绞痛患者,随机分为两组,观察组和对照组,每组53例。观察组患者应用血脂康进行治疗,对照组患者应用辛伐他汀进行治疗。对比分析两组患者的治疗效果。结果观察组与对照组TC、LDL-C无明显差异,P>0.05。观察组患者TG、HDL-C检测值分别为(2.18±1.01)mmol/L、(2.20±0.71)mmol/L,对照组患者TG、HDL-C检测值分别为(3.10±1.81)mmol/L、(1.69±0.53)mmol/L,观察组TG、HDL-C检测值均显著优于对照组,两组比较差异性显著(P<0.05)。结论相对辛伐他汀而言,血脂康对于不稳定性心绞痛患者有着更加良好的调脂作用,值得临床借鉴应用。
Objective Xuezhikang of unstable angina and simvastatin for lipid-lowering effects. Methods Selected 106 cases of unstable angina were randomly divided into two groups, the observation group and control group 53 cases. Xuezhikang observation group patients treated control group of patients treated with simvastatin. Comparative analysis of two groups of patient outcomes. Results. Observation group and control group TC, LDL-C was no significant difference,P〉 0.05. The patients TG, HDL-C values were （2.18±1.01） mmol/ L, （2.20± 0.71） mmol / L, control group patients TG, HDL-C values were （3.10±1.81） mmol / L, （1.69 i 0.53 ）mmol/ L, the observation group TG, HDL-C test values were significantly better than the control group, the difference was significantly （P〈0.05）, with statistical significance. Conclusion Relative to simvastatin, the Xuezhikang for patients with unstable angina have a more favorable lipid, worthy of clinical reference applications.
出处
《当代医学》
2011年第34期128-129,共2页
Contemporary Medicine
